Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
These Analysts Boost Their Forecasts On Johnson & Johnson After Upbeat Q3 Earnings
02:04pm, Wednesday, 15'th Oct 2025
Johnson & Johnson (NYSE:JNJ) on Tuesday reported better-than-expected third-quarter earnings on Tuesday.
Johnson & Johnson Rules Out Big Acquisitions, Reiterates Focus On Small Deals: Analyst
01:56pm, Wednesday, 15'th Oct 2025
On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter 2025 adjusted earnings of $2.80 per share, up 15.7% year over year, beating the consensus of $2.75.
2 Dividend Stocks I'm Very Thankful I Owned This Year
01:03pm, Wednesday, 15'th Oct 2025
We narrowly escaped a sustained stock meltdown this year. In April, the S&P 500 briefly sank into bear-market territory due to investors' fears about the impact of President Donald Trump's tariffs on
Johnson & Johnson's MedTech spin-off could boost focus, Bank of America says
12:49pm, Wednesday, 15'th Oct 2025
Bank of America maintained a ‘Neutral' rating on Johnson & Johnson (NYSE:JNJ) after the company posted third-quarter results slightly above expectations and hinted at a strategic MedTech shake-up. I
Johnson & Johnson Stock Can Keep Rising as Strategy Pays Off
12:16pm, Wednesday, 15'th Oct 2025
Johnson & Johnson's NYSE: JNJ stock price can continue to advance because its strategy to reinvigorate growth and widen margins is working. The plan centers on divesting underperforming healthcare bu
Johnson & Johnson’s MedTech spin-off could boost focus, Bank of America says
08:45am, Wednesday, 15'th Oct 2025
Bank of America maintained a ‘Neutral’ rating on Johnson & Johnson (NYSE:JNJ) after the company posted third-quarter results slightly above expectations and...
Johnson & Johnson reveals 2025 sales forecast and plans for its orthopedics business
07:51am, Wednesday, 15'th Oct 2025
Johnson & Johnson on Tuesday raised its 2025 sales forecast after reporting quarterly earnings that topped Wall Street expectations, and announced plans to spin off its orthopedics business into a sta
This 2.7%-Yielding Dividend King Remains One of the Healthiest Income Stocks You Can Buy
05:20am, Wednesday, 15'th Oct 2025
Johnson & Johnson (JNJ -0.02%) is one of the world's best dividend stocks. The healthcare giant has increased its dividend payment for 63 consecutive years.
'NEVER BEEN STRONGER': Johnson & Johnson leader touts latest innovations
07:30pm, Tuesday, 14'th Oct 2025
Johnson & Johnson CFO and Executive Vice President Joe Wolk addresses the decision to spin off its orthopedics business, explains its innovations and more on ‘The Claman Countdown.' #fox #media #bre
JNJ Beats on Q3 Earnings, Ups Sales View, to Spin-off Orthopaedics Unit
01:01pm, Tuesday, 14'th Oct 2025
J&J tops Q3 forecasts, lifts 2025 sales outlook and plans to spin off its struggling Orthopaedics business.
Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?
12:47pm, Tuesday, 14'th Oct 2025
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
Johnson & Johnson (JNJ) Q3 2025 Earnings Call Transcript
12:36pm, Tuesday, 14'th Oct 2025
Johnson & Johnson (NYSE:JNJ ) Q3 2025 Earnings Call October 14, 2025 8:30 AM EDT Company Participants Darren Snellgrove - Vice President of Investor Relations Joaquin Duato - CEO & Chairman Joseph Wol
3 Dividend Aristocrats to Buy that Continued to Beat the Market
11:25am, Tuesday, 14'th Oct 2025
Finding top dividend stocks to invest in is one thing. Finding companies that can pay that dividend for years, and potentially decades, to come is a whole other story.
Compared to Estimates, Johnson & Johnson (JNJ) Q3 Earnings: A Look at Key Metrics
10:31am, Tuesday, 14'th Oct 2025
Although the revenue and EPS for Johnson & Johnson (JNJ) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with
Johnson & Johnson Stock Brushes Off Beat-and-Raise
10:05am, Tuesday, 14'th Oct 2025
Johnson & Johnson (NYSE:JNJ) stock is down 1.2% to trade at $188.54 at last glance, brushing off an earnings and revenue beat for the third quarter.
